The schedule fight: what actually happened to the American childhood vaccine schedule

Between December 2025 and August 2026 the United States tried three times to rewrite the childhood immunisation schedule — first by departmental memorandum, then by executive order, then by a second executive order. A federal judge stopped the first attempt in March. The advisory committee that would have to carry out the other two has not been able to meet since December 2025. This page sets out what the documents say, because the episode is already being described in Canada as though something had been settled.

A QuackeryWatch record · Posted 22 October 2026 · build 22-10-D · Companion to the RFK Jr. running file and the CHD racketeering suit

Where it stands today

Start at the end, because the end is simpler than the middle.

• The childhood immunisation schedule published by the CDC today is the one that was in force in 2025. The January 2026 revision was stayed and has never taken effect.
• ACIP has not met since December 2025. Three meetings have been cancelled this year, most recently the one scheduled for 21–23 October, which the CDC's own page says is cancelled “due to ongoing litigation.”
• The injunction remains in force. The district court case is stayed while the appeal proceeds.
• The appeal, No. 26-1503 in the First Circuit, was argued on 6 October 2026. No decision has issued.
• The second executive order gave HHS ninety days to present plans. That falls due in early November 2026.

So three federal attempts to change the schedule have produced, so far, no change to the schedule.

The sequence

The January cut, and what it actually did

The decision memorandum of 5 January 2026 kept eleven diseases under universal recommendation: measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, pneumococcal disease, HPV and varicella.

It moved others. Hepatitis A, meningococcal ACWY and RSV went to risk-based or shared clinical decision-making. Rotavirus and influenza went to shared clinical decision-making. HPV went from two or three doses to one. The 2025 changes to the COVID-19 and hepatitis B recommendations were folded in.

“Shared clinical decision-making” is the category that does the work here. A vaccine in it is not withdrawn, not banned, and not declared unsafe; it is no longer recommended for everyone, and is instead to be discussed case by case. The departmental assessment that preceded the memorandum was explicit that “no vaccine should be moved to the ‘not recommended' category.”

Why a judge stopped it

The American Academy of Pediatrics and other medical organisations had sued the Secretary of Health and Human Services in July 2025 over an earlier change. By early 2026 that case had grown into a challenge to the reconstitution of ACIP and to everything the committee did afterwards. On 16 March 2026, Judge Brian E. Murphy granted preliminary relief, in an order running to forty-five pages.

He stayed the January memorandum. He stayed the appointments of thirteen of the fifteen sitting ACIP members. And he stayed every vote the reconstituted committee had taken.

Two reasons, and they are worth separating because they are different kinds of argument.

The statutory reason. Congress wrote ACIP into several statutes by name — insurance coverage without cost sharing, the Vaccines for Children programme, and others — each tying a federal obligation to an ACIP recommendation. The court found that “Congress has required ACIP's involvement in the issuance of the immunization schedules,” and that on the government's reading “Congress's mention of ACIP would be rendered pure surplusage.” There was, it said, “no explanation, let alone a reasoned one” for bypassing the committee. And pointedly: “Defendants cannot disregard the APA's requirements simply because they are following the President's orders.”

The committee-composition reason. Under the Federal Advisory Committee Act an advisory committee must be fairly balanced. The court found that “only six of fifteen members had ‘any meaningful experience in vaccines',” that “a committee of non-experts cannot be said to embody” fair balance, and that the appointment process — and therefore the whole committee — “was tainted.”

The two executive orders, and the door they point at

Executive Order 14407, signed 29 May 2026, acknowledges the January assessment as “a guiding resource” and directs the CDC and ACIP, “to the extent permitted by law,” to take appropriate steps to update the schedule. It provides that scheduled immunisations should continue to be covered without cost sharing. It states that it “does not, create any right or benefit, substantive or procedural, enforceable at law.”

Executive Order 14420, signed 10 August 2026, is more specific. It opens by acknowledging that implementation of the earlier directives “has been delayed due to litigation over the composition of the Advisory Committee on Immunization Practices.” It sorts immunisations into three categories. Eleven are to be universally recommended: “measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus, and varicella.” A high-risk group covers RSV antibodies, hepatitis A and B, meningococcal B and ACWY, and dengue. A shared-decision group covers hepatitis A and B, rotavirus, meningococcal disease, influenza and COVID-19. Hepatitis A, hepatitis B and meningococcal disease appear in two categories at once; the order does not reconcile this, and the same overlap appears in the department’s January fact sheet. It directs that “the combined measles, mumps, rubella (MMR) vaccine should be administered in three separate single-disease shots” once such products are available domestically, and that “to the maximum extent feasible, all childhood immunizations should be administered at separate medical visits.” It gives HHS ninety days to present plans. And at section 4 it directs the Attorney General to “take appropriate measures to further meritorious legal actions challenging State laws” — litigation to be brought, not a change already made, but the one part of the order aimed squarely at the state requirements that actually govern school entry. It too creates no enforceable rights.

Three committees, and only one of them matters

In July and August 2026 the department rewrote the charter of one vaccine advisory committee, renewed another, and advertised for members of the first. This has been read in some quarters as a route around the injunction. It is not, and the reason is worth setting out, because the three bodies are routinely discussed as though they were interchangeable.

ACIP — the Advisory Committee on Immunization Practices — is the one that matters, and there is something odd about it: Congress never created it. It exists under a general provision of the Public Health Service Act, 42 U.S.C. § 217a, which lets the Secretary set up an advisory committee on more or less anything. Its power comes from Congress having later written it into other statutes by name. Private health plans must cover immunisations carrying an ACIP recommendation, without cost sharing (42 U.S.C. § 300gg-13(a)(2)). The Vaccines for Children programme buys from the ACIP list (42 U.S.C. § 1396s). So ACIP reaches insurance coverage and federal vaccine purchasing — and, indirectly, the state school requirements that point at the CDC schedule.

NVAC — the National Vaccine Advisory Committee — was created by Congress, in the 1986 vaccine act, at 42 U.S.C. § 300aa-5. It advises the Director of the National Vaccine Program, a role held by the Assistant Secretary for Health, and it sits outside the CDC entirely. Its statutory jobs are vaccine supply, research priorities, advice on programme implementation, and an annual report. Nothing it produces has legal consequence. No insurer's obligation changes because of an NVAC report.

ACCV — the Advisory Commission on Childhood Vaccines — also comes from the 1986 act, at 42 U.S.C. § 300aa-19. Nine members, housed at the Health Resources and Services Administration. Its jurisdiction is the injury compensation programme: the Vaccine Injury Table and the vaccine information statements. It concerns what happens after a child is injured, not which immunisations a child receives.

So the two committees Congress actually wrote into the vaccine statute have no authority over the schedule, and the committee Congress left out of that statute is the one that drives it. Changing the first two cannot move the schedule, and did not.

Of the two July filings, only one was a rewrite. The ACCV renewal of 21 July 2026 was routine — the ordinary two-year recharter, the previous one having been filed in July 2024, with no substantive change stated in either the notice or the charter. It has nonetheless been presented as part of a pattern. It is not.

What none of this changed

School requirements. These are state law. A federal recommendation is not a mandate, and a presidential order directed at a federal advisory committee does not reach a state statute. No child's school entry requirements changed because of anything on this page.

Availability. No vaccine was withdrawn, banned, or found unsafe in any of these documents. The assessment that began the process said in terms that none should be moved to “not recommended.”

The published schedule. The CDC's current childhood and adolescent schedule is the 2025 one. The revision that attracted the attention has never been in effect.

Canada. NACI sets immunisation recommendations here. Nothing in an American executive order, a CDC memorandum or a Massachusetts injunction alters a Canadian recommendation, and no Canadian parent should change anything on the strength of them.

Why this belongs on a Canadian site

Because it is already being used here. A reader who is shown “the President has ordered the vaccine schedule reduced” or “the CDC cut the schedule from seventeen vaccines to eleven” is being told something that is partly true, out of date, and missing the part where a court stayed it and the committee has not met since.

The useful question is the same one this site asks of every document: has anything actually been decided, and by whom? Here the answer is that a department tried, a court stopped it, two executive orders have told an immobilised committee to try again, and an appeal argued three weeks ago has not been decided.

A note on how this page is written

Every factual claim here comes from a government document, a court order, the Congressional Research Service, mainstream news reporting, or a professional body's own statement. Advocacy sources were excluded in both directions — no material from anti-vaccine organisations and none from campaigning groups on the other side either. Where permitted sources disagree, as they do on the “seventeen” figure, this page says so rather than choosing the tidier number.

Some of the underlying material was read in secondary form. The operative ordering language of the March injunction is taken from the court docket and corroborated by the government's own appellate brief rather than read in the body of the opinion, where the text of the final pages was not retrievable. That limitation is recorded here rather than hidden.

Corrections are welcome and will be posted.